Skip to main content
Premium Trial:

Request an Annual Quote

Agendia Joins Personalized Medicine Coalition

NEW YORK (GenomeWeb News) - Dutch diagnostics maker Agendia said today it has joined the Personalized Medicine Coalition, a consortium focused on public policy and regulatory issues related to the adoption of personalized medicine.
Agendia makes MammaPrint, an in vitro diagnostic multivariate index assay for breast cancer recurrence that was the first such test to be cleared by the US Food and Drug Administration.
Now that the Amsterdam-based firm is marketing the test in the US, "we believe it is now time to actively participate in the discussion about the implementation of personalized medicine in the US," company CEO Bernhard Sixt said in a statement.
The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.